Study shows promise of new anti-KRAS drug for pancreatic cancer
by Perelman School of Medicine at the University of PennsylvaniaMRTX1133 reduces metastatic burden in a tail vein model. (A) Representative brightfield images of lungs from vehicle and MRTX1133 (
Updated on: January 30,2024
12
Study shows promise of new anti-KRAS drug for pancreatic cancer
by Perelman School of Medicine at the University of PennsylvaniaMRTX1133 reduces metastatic burden in a tail vein model. (A) Representative brightfield images of lungs from vehicle and MRTX1133 (
Updated on:January 30,2024
12
